Structure

Physi-Chem Properties

Molecular Weight:  316.09
Volume:  305.285
LogP:  2.676
LogD:  3.181
LogS:  -3.983
# Rotatable Bonds:  2
TPSA:  77.38
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.886
Synthetic Accessibility Score:  3.048
Fsp3:  0.294
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.964
MDCK Permeability:  2.0309722458478063e-05
Pgp-inhibitor:  0.01
Pgp-substrate:  0.167
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.014

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.04
Plasma Protein Binding (PPB):  99.23930358886719%
Volume Distribution (VD):  0.736
Pgp-substrate:  1.4517885446548462%

ADMET: Metabolism

CYP1A2-inhibitor:  0.961
CYP1A2-substrate:  0.718
CYP2C19-inhibitor:  0.894
CYP2C19-substrate:  0.22
CYP2C9-inhibitor:  0.652
CYP2C9-substrate:  0.811
CYP2D6-inhibitor:  0.931
CYP2D6-substrate:  0.907
CYP3A4-inhibitor:  0.912
CYP3A4-substrate:  0.374

ADMET: Excretion

Clearance (CL):  17.579
Half-life (T1/2):  0.489

ADMET: Toxicity

hERG Blockers:  0.057
Human Hepatotoxicity (H-HT):  0.165
Drug-inuced Liver Injury (DILI):  0.728
AMES Toxicity:  0.548
Rat Oral Acute Toxicity:  0.317
Maximum Recommended Daily Dose:  0.962
Skin Sensitization:  0.943
Carcinogencity:  0.876
Eye Corrosion:  0.003
Eye Irritation:  0.876
Respiratory Toxicity:  0.804

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC307466

Natural Product ID:  NPC307466
Common Name*:   Hildegardiol
IUPAC Name:   (3R)-3-(6-hydroxy-1,3-benzodioxol-5-yl)-7-methoxy-3,4-dihydro-2H-chromen-6-ol
Synonyms:   hildegardiol
Standard InCHIKey:  MBIKSISXYLIKEM-JTQLQIEISA-N
Standard InCHI:  InChI=1S/C17H16O6/c1-20-15-6-14-9(3-13(15)19)2-10(7-21-14)11-4-16-17(5-12(11)18)23-8-22-16/h3-6,10,18-19H,2,7-8H2,1H3/t10-/m0/s1
SMILES:  COc1cc2OC[C@H](Cc2cc1O)c1cc2OCOc2cc1O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL507844
PubChem CID:   11623832
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0002586] O-methylated isoflavonoids
          • [CHEMONTID:0002602] 7-O-methylated isoflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22979 Hildegardia barteri Species Malvaceae Eukaryota n.a. n.a. n.a. PMID[16378378]
NPO22979 Hildegardia barteri Species Malvaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20 Organism Candida albicans Candida albicans IC50 > 128.0 ug.mL-1 PMID[542979]
NPT554 Organism Candida glabrata Candida glabrata IC50 > 128.0 ug.mL-1 PMID[542979]
NPT20 Organism Candida albicans Candida albicans IC50 >= 64.0 ug.mL-1 PMID[542979]
NPT554 Organism Candida glabrata Candida glabrata IC50 >= 64.0 ug.mL-1 PMID[542979]
NPT187 Organism Issatchenkia orientalis Pichia kudriavzevii IC50 > 128.0 ug.mL-1 PMID[542979]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC307466 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9645 High Similarity NPC301961
0.9645 High Similarity NPC166584
0.9643 High Similarity NPC226540
0.9565 High Similarity NPC247291
0.9562 High Similarity NPC30951
0.9562 High Similarity NPC6369
0.9507 High Similarity NPC71726
0.9496 High Similarity NPC107161
0.9493 High Similarity NPC284464
0.9433 High Similarity NPC474749
0.9433 High Similarity NPC11422
0.9433 High Similarity NPC42716
0.9433 High Similarity NPC178014
0.9429 High Similarity NPC102044
0.9429 High Similarity NPC47633
0.9429 High Similarity NPC81638
0.9429 High Similarity NPC85264
0.942 High Similarity NPC319647
0.942 High Similarity NPC25966
0.942 High Similarity NPC245207
0.942 High Similarity NPC127218
0.9416 High Similarity NPC197166
0.9384 High Similarity NPC159922
0.9375 High Similarity NPC472709
0.9375 High Similarity NPC472710
0.9371 High Similarity NPC175976
0.9366 High Similarity NPC162193
0.9362 High Similarity NPC12641
0.9362 High Similarity NPC280092
0.9362 High Similarity NPC45257
0.9362 High Similarity NPC63879
0.9362 High Similarity NPC93323
0.9353 High Similarity NPC309124
0.9353 High Similarity NPC259519
0.9353 High Similarity NPC254759
0.9353 High Similarity NPC184797
0.9353 High Similarity NPC160283
0.9353 High Similarity NPC27495
0.9348 High Similarity NPC276490
0.9301 High Similarity NPC39657
0.9301 High Similarity NPC227902
0.9286 High Similarity NPC471389
0.9286 High Similarity NPC311530
0.9281 High Similarity NPC236306
0.9281 High Similarity NPC473739
0.9281 High Similarity NPC292487
0.9281 High Similarity NPC292882
0.9281 High Similarity NPC232164
0.9281 High Similarity NPC9068
0.9275 High Similarity NPC270456
0.9275 High Similarity NPC173660
0.9275 High Similarity NPC248727
0.9275 High Similarity NPC162659
0.9275 High Similarity NPC265433
0.9236 High Similarity NPC248132
0.9236 High Similarity NPC130449
0.9231 High Similarity NPC99515
0.9231 High Similarity NPC190714
0.9225 High Similarity NPC473046
0.9225 High Similarity NPC472712
0.9225 High Similarity NPC118385
0.9225 High Similarity NPC472713
0.9225 High Similarity NPC187774
0.922 High Similarity NPC80326
0.9214 High Similarity NPC177868
0.9209 High Similarity NPC103976
0.9209 High Similarity NPC326797
0.9209 High Similarity NPC102904
0.9209 High Similarity NPC107551
0.9209 High Similarity NPC474039
0.9209 High Similarity NPC176051
0.9209 High Similarity NPC474282
0.9203 High Similarity NPC195022
0.9172 High Similarity NPC240521
0.9172 High Similarity NPC51328
0.9172 High Similarity NPC286235
0.9172 High Similarity NPC55158
0.9167 High Similarity NPC21776
0.9167 High Similarity NPC16269
0.9167 High Similarity NPC101376
0.9161 High Similarity NPC180953
0.9161 High Similarity NPC475096
0.9161 High Similarity NPC277867
0.9161 High Similarity NPC161700
0.9155 High Similarity NPC474808
0.9155 High Similarity NPC477616
0.9155 High Similarity NPC472451
0.9155 High Similarity NPC252169
0.9149 High Similarity NPC300798
0.9149 High Similarity NPC58137
0.9143 High Similarity NPC70682
0.9143 High Similarity NPC260741
0.9143 High Similarity NPC471388
0.913 High Similarity NPC317380
0.9124 High Similarity NPC127624
0.911 High Similarity NPC238140
0.9103 High Similarity NPC270751
0.9097 High Similarity NPC125755
0.9091 High Similarity NPC25292
0.9091 High Similarity NPC121661
0.9091 High Similarity NPC73467
0.9091 High Similarity NPC473045
0.9085 High Similarity NPC472714
0.9085 High Similarity NPC191231
0.9085 High Similarity NPC5262
0.9085 High Similarity NPC41782
0.9085 High Similarity NPC174522
0.9085 High Similarity NPC133934
0.9085 High Similarity NPC184641
0.9085 High Similarity NPC184684
0.9085 High Similarity NPC189115
0.9085 High Similarity NPC475084
0.9065 High Similarity NPC470356
0.9065 High Similarity NPC94750
0.9065 High Similarity NPC112246
0.9065 High Similarity NPC474206
0.9065 High Similarity NPC121812
0.9065 High Similarity NPC260898
0.9065 High Similarity NPC134968
0.9065 High Similarity NPC234333
0.9065 High Similarity NPC112939
0.9065 High Similarity NPC47398
0.9058 High Similarity NPC471391
0.9058 High Similarity NPC471390
0.9054 High Similarity NPC78809
0.9034 High Similarity NPC31325
0.9034 High Similarity NPC213074
0.9034 High Similarity NPC114505
0.9034 High Similarity NPC275284
0.9034 High Similarity NPC193473
0.9034 High Similarity NPC224674
0.9034 High Similarity NPC15956
0.9034 High Similarity NPC116019
0.9028 High Similarity NPC197352
0.9028 High Similarity NPC189239
0.9028 High Similarity NPC166506
0.9028 High Similarity NPC205316
0.9028 High Similarity NPC110763
0.9021 High Similarity NPC298317
0.9021 High Similarity NPC37793
0.9021 High Similarity NPC185071
0.9021 High Similarity NPC470950
0.9021 High Similarity NPC12728
0.9021 High Similarity NPC473044
0.9021 High Similarity NPC185307
0.9021 High Similarity NPC255566
0.9014 High Similarity NPC35216
0.9014 High Similarity NPC87725
0.9014 High Similarity NPC263261
0.9014 High Similarity NPC469661
0.9 High Similarity NPC16435
0.9 High Similarity NPC472334
0.9 High Similarity NPC474639
0.9 High Similarity NPC472336
0.9 High Similarity NPC230734
0.9 High Similarity NPC172818
0.9 High Similarity NPC227503
0.9 High Similarity NPC306441
0.9 High Similarity NPC25695
0.8993 High Similarity NPC474478
0.8993 High Similarity NPC106215
0.8986 High Similarity NPC175067
0.8986 High Similarity NPC6451
0.8986 High Similarity NPC204215
0.8986 High Similarity NPC86655
0.8986 High Similarity NPC202762
0.898 High Similarity NPC24425
0.8978 High Similarity NPC214860
0.8966 High Similarity NPC33832
0.8966 High Similarity NPC154971
0.8966 High Similarity NPC252286
0.8958 High Similarity NPC470235
0.8958 High Similarity NPC469313
0.8958 High Similarity NPC283995
0.8958 High Similarity NPC129417
0.8958 High Similarity NPC50250
0.8958 High Similarity NPC168579
0.8958 High Similarity NPC138227
0.8958 High Similarity NPC76176
0.8951 High Similarity NPC2613
0.8951 High Similarity NPC204347
0.8951 High Similarity NPC253878
0.8951 High Similarity NPC472562
0.8951 High Similarity NPC475891
0.8951 High Similarity NPC476356
0.8951 High Similarity NPC59841
0.8951 High Similarity NPC469559
0.8944 High Similarity NPC226547
0.8936 High Similarity NPC211549
0.8929 High Similarity NPC61946
0.8929 High Similarity NPC472337
0.8929 High Similarity NPC151224
0.8921 High Similarity NPC168059
0.8921 High Similarity NPC158331
0.8921 High Similarity NPC196937
0.8921 High Similarity NPC11060
0.8921 High Similarity NPC229442
0.8913 High Similarity NPC474356
0.8913 High Similarity NPC45715
0.8913 High Similarity NPC232275

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC307466 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8759 High Similarity NPD1530 Clinical (unspecified phase)
0.8714 High Similarity NPD1613 Approved
0.8714 High Similarity NPD1612 Clinical (unspecified phase)
0.8696 High Similarity NPD1529 Clinical (unspecified phase)
0.85 High Similarity NPD3027 Phase 3
0.8411 Intermediate Similarity NPD1653 Approved
0.8397 Intermediate Similarity NPD6234 Discontinued
0.8298 Intermediate Similarity NPD4908 Phase 1
0.8227 Intermediate Similarity NPD2861 Phase 2
0.8194 Intermediate Similarity NPD37 Approved
0.8188 Intermediate Similarity NPD1610 Phase 2
0.8182 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD7199 Phase 2
0.8153 Intermediate Similarity NPD4966 Approved
0.8153 Intermediate Similarity NPD4965 Approved
0.8153 Intermediate Similarity NPD4967 Phase 2
0.8148 Intermediate Similarity NPD7228 Approved
0.8121 Intermediate Similarity NPD6674 Discontinued
0.8075 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8058 Intermediate Similarity NPD3705 Approved
0.8037 Intermediate Similarity NPD3818 Discontinued
0.7962 Intermediate Similarity NPD1934 Approved
0.7943 Intermediate Similarity NPD4749 Approved
0.7939 Intermediate Similarity NPD7074 Phase 3
0.7911 Intermediate Similarity NPD2801 Approved
0.7879 Intermediate Similarity NPD7054 Approved
0.7831 Intermediate Similarity NPD7472 Approved
0.7812 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7808 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7801 Intermediate Similarity NPD1091 Approved
0.7799 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7798 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.777 Intermediate Similarity NPD1548 Phase 1
0.774 Intermediate Similarity NPD4625 Phase 3
0.7702 Intermediate Similarity NPD3882 Suspended
0.7679 Intermediate Similarity NPD6797 Phase 2
0.7669 Intermediate Similarity NPD5494 Approved
0.7633 Intermediate Similarity NPD7251 Discontinued
0.7633 Intermediate Similarity NPD7240 Approved
0.7632 Intermediate Similarity NPD7266 Discontinued
0.7603 Intermediate Similarity NPD3018 Phase 2
0.759 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD6166 Phase 2
0.759 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7588 Intermediate Similarity NPD7808 Phase 3
0.7584 Intermediate Similarity NPD4060 Phase 1
0.7564 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.756 Intermediate Similarity NPD5844 Phase 1
0.7546 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7536 Intermediate Similarity NPD5283 Phase 1
0.7529 Intermediate Similarity NPD6559 Discontinued
0.7516 Intermediate Similarity NPD3382 Approved
0.7516 Intermediate Similarity NPD3383 Approved
0.7516 Intermediate Similarity NPD3384 Approved
0.75 Intermediate Similarity NPD5058 Phase 3
0.75 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7549 Discontinued
0.7469 Intermediate Similarity NPD1465 Phase 2
0.7467 Intermediate Similarity NPD3620 Phase 2
0.7467 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7465 Intermediate Similarity NPD1357 Approved
0.7457 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD1511 Approved
0.7448 Intermediate Similarity NPD2983 Phase 2
0.7448 Intermediate Similarity NPD2982 Phase 2
0.7429 Intermediate Similarity NPD6671 Approved
0.7423 Intermediate Similarity NPD3817 Phase 2
0.7421 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD228 Approved
0.7379 Intermediate Similarity NPD2981 Phase 2
0.7358 Intermediate Similarity NPD1512 Approved
0.7358 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD6100 Approved
0.7338 Intermediate Similarity NPD6099 Approved
0.7333 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD1375 Discontinued
0.7279 Intermediate Similarity NPD6696 Suspended
0.7267 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD3787 Discontinued
0.7261 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD2978 Approved
0.7256 Intermediate Similarity NPD2977 Approved
0.7251 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD3021 Approved
0.7246 Intermediate Similarity NPD3022 Approved
0.7237 Intermediate Similarity NPD1558 Phase 1
0.7222 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD1652 Phase 2
0.7192 Intermediate Similarity NPD422 Phase 1
0.719 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD5124 Phase 1
0.719 Intermediate Similarity NPD6355 Discontinued
0.7188 Intermediate Similarity NPD7447 Phase 1
0.7179 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD4675 Approved
0.7178 Intermediate Similarity NPD4678 Approved
0.7162 Intermediate Similarity NPD8651 Approved
0.7161 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD5588 Approved
0.716 Intermediate Similarity NPD6232 Discontinued
0.7152 Intermediate Similarity NPD3892 Phase 2
0.7152 Intermediate Similarity NPD7466 Approved
0.7152 Intermediate Similarity NPD8455 Phase 2
0.7135 Intermediate Similarity NPD7680 Approved
0.7135 Intermediate Similarity NPD7473 Discontinued
0.7126 Intermediate Similarity NPD7075 Discontinued
0.7126 Intermediate Similarity NPD7685 Pre-registration
0.7125 Intermediate Similarity NPD7212 Phase 2
0.7125 Intermediate Similarity NPD7213 Phase 3
0.7119 Intermediate Similarity NPD4663 Approved
0.7117 Intermediate Similarity NPD4005 Discontinued
0.7102 Intermediate Similarity NPD8053 Approved
0.7102 Intermediate Similarity NPD8054 Approved
0.7097 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD4536 Approved
0.7097 Intermediate Similarity NPD4538 Approved
0.7095 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD3751 Discontinued
0.7089 Intermediate Similarity NPD5177 Phase 3
0.7081 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD7906 Approved
0.7079 Intermediate Similarity NPD6841 Approved
0.7079 Intermediate Similarity NPD6843 Phase 3
0.7079 Intermediate Similarity NPD6842 Approved
0.7076 Intermediate Similarity NPD27 Approved
0.7076 Intermediate Similarity NPD2489 Approved
0.7073 Intermediate Similarity NPD4380 Phase 2
0.707 Intermediate Similarity NPD5762 Approved
0.707 Intermediate Similarity NPD5763 Approved
0.707 Intermediate Similarity NPD3540 Phase 1
0.707 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD7157 Approved
0.7059 Intermediate Similarity NPD6233 Phase 2
0.7059 Intermediate Similarity NPD7229 Phase 3
0.7055 Intermediate Similarity NPD5125 Phase 3
0.7055 Intermediate Similarity NPD5126 Approved
0.7051 Intermediate Similarity NPD4108 Discontinued
0.705 Intermediate Similarity NPD2684 Approved
0.7048 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD7819 Suspended
0.7045 Intermediate Similarity NPD7313 Approved
0.7045 Intermediate Similarity NPD7312 Approved
0.7045 Intermediate Similarity NPD7311 Approved
0.7045 Intermediate Similarity NPD4577 Approved
0.7045 Intermediate Similarity NPD4578 Approved
0.7045 Intermediate Similarity NPD7310 Approved
0.7044 Intermediate Similarity NPD3750 Approved
0.7044 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD6331 Phase 2
0.7044 Intermediate Similarity NPD4110 Phase 3
0.7039 Intermediate Similarity NPD7095 Approved
0.703 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD968 Approved
0.7025 Intermediate Similarity NPD1549 Phase 2
0.7018 Intermediate Similarity NPD2970 Approved
0.7018 Intermediate Similarity NPD2969 Approved
0.7007 Intermediate Similarity NPD3496 Discontinued
0.7006 Intermediate Similarity NPD3539 Phase 1
0.7006 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5402 Approved
0.7006 Intermediate Similarity NPD3454 Phase 3
0.7006 Intermediate Similarity NPD7309 Approved
0.7 Intermediate Similarity NPD4750 Phase 3
0.7 Intermediate Similarity NPD5084 Clinical (unspecified phase)
0.6993 Remote Similarity NPD6798 Discontinued
0.6987 Remote Similarity NPD7097 Phase 1
0.6975 Remote Similarity NPD1754 Clinical (unspecified phase)
0.6972 Remote Similarity NPD7843 Approved
0.6968 Remote Similarity NPD230 Phase 1
0.6968 Remote Similarity NPD5735 Approved
0.6959 Remote Similarity NPD3051 Approved
0.6957 Remote Similarity NPD7124 Phase 2
0.6954 Remote Similarity NPD6584 Phase 3
0.6946 Remote Similarity NPD5929 Approved
0.6944 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6943 Remote Similarity NPD5960 Phase 3
0.6918 Remote Similarity NPD970 Clinical (unspecified phase)
0.6914 Remote Similarity NPD6799 Approved
0.6914 Remote Similarity NPD4357 Discontinued
0.6905 Remote Similarity NPD2560 Approved
0.6905 Remote Similarity NPD2563 Approved
0.6901 Remote Similarity NPD1247 Approved
0.6901 Remote Similarity NPD6959 Discontinued
0.6899 Remote Similarity NPD2935 Discontinued
0.6897 Remote Similarity NPD7340 Approved
0.6894 Remote Similarity NPD2677 Approved
0.6894 Remote Similarity NPD6190 Approved
0.6887 Remote Similarity NPD2797 Approved
0.6879 Remote Similarity NPD6111 Discontinued
0.6879 Remote Similarity NPD4978 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data